Endometrial Cancer
Sometimes a small gesture can save a life. Just ask this survivor. Read More ›
Find financial assistance programs available for endometrial (uterine) cancer drugs. Read More ›
From their “Survivors’ Sanctuary” to their collaboration with academic researchers, the Endometrial Cancer Action Network for African-Americans (ECANA) is a national organization dedicated to improving the lives of Black women with endometrial cancer. Read More ›
Dr. Binder, of the University of California, San Diego, describes immunotherapy as the most recent advance in the treatment of endometrial cancer. Read More ›
For young adults facing a cancer diagnosis, consideration of fertility preservation is an important component of the treatment plan. Read More ›
Ms. Shockney offers thoughts about education after a diagnosis as the key to empowering women facing this disease. Read More ›
There are more effective treatment options available to you today than ever before. Here, Ms. Atkinson outlines treatments by stage. Read More ›
A diagnosis of endometrial cancer comes with a new vocabulary. These are the terms you need to know. Read More ›
In April 2021, the FDA approved Jemperli (dostarlimab-gxly) for patients with recurrent or advanced endometrial cancer and the biomarker mismatch repair-deficient. This is the first immunotherapy approved for patients with this type of cancer. Read More ›